Showing results (1-10 of 601) with videos related to
Sort By:
Pageof 61
Expert Review of Cardiovascular Therapy|November 23, 2011
The proarrhythmic risk of cell therapy for cardiovascular diseasesYuan Liu, Hung-Fat TseJournal of Clinical Medicine|December 23, 2022
Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery DiseaseChor-Cheung Tam, Hung-Fat TsePacing and Clinical Electrophysiology : PACE|January 11, 2003
Bleeding and thromboembolic risks of internal cardioversion for persistent atrial fibrillationHung-Fat Tse, Chu-Pak LauJournal of Cardiovascular Pharmacology and Therapeutics|June 15, 2007
Therapeutic angiogenesis with bone marrow--derived stem cellsHung-Fat Tse, Chu-Pak LauCardiology Clinics|March 5, 2004
Future prospects for implantable devices for atrial defibrillationHung-Fat Tse, Chu-Pak LauJournal of the American College of Cardiology|December 31, 2002
Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillationHung-Fat Tse, Chu-Pak LauFrontiers in Cardiovascular Medicine|October 18, 2021
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular DiseaseYuen-Kwun Wong, Hung-Fat TseCatheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 30, 2009
Microvascular obstruction after percutaneous coronary interventionChi-Hang Lee, Hung-Fat TsePacing and Clinical Electrophysiology : PACE|August 22, 2003
Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversionHung-Fat Tse, Chu Pap LauCardiac Electrophysiology Review|April 9, 2004
Does sinus rhythm beget sinus rhythm? Effects of prompt cardioversion on the frequency and persistence of recurrent atrial fibrillationHung-Fat Tse, Chu-Pak LauPageof 61